课题基金 / 基金详情

GORDON CONFERENCE ON FIBRONECTIN, INTEGRINS

GORDON CONFERENCE ON FIBRONECTIN, INTEGRINS
纤维连接蛋白、整合素戈登会议
批准号:
2010806
负责人:
MARTIN E HEMLER
金额:
$0.7万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-01-26 至 1998-01-25

项目摘要

项目成果

MARTIN E HEMLER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Applicant's Description) Research on fibronectin and integrins has expanded greatly in the last 10-20 years. These molecules control many basic biological functions such as cell adhesion, determination of cell shape and differentiation, organ and tissue development, hematopoiesis, immune cell function, tumorigenicity and metastasis, cell migration, cytoskeletal organization, and organization of the extracellular matrix. More recently, it has become obvious that integrins collaborate with growth factors to regulate cell proliferation and apoptosis, and thus have a major involvement in cell signaling. In addition, several of the integrins, including Alpha-2b-beta-3 on platelets, alpha-5-beta-3 on tumor blood vessels, and alpha-4 integrins on immune cells, have become widely recognized as targets for therapeutic intervention. The overall importance of fibronectin and integrins is further emphasized by the results from several knockout mouse experiments. In many cases, null/null mutations have produced embryonic lethal or perinatal lethal phenotypes. The challenge for the cell adhesion field over the next several years will be to comprehend and organize the large amount of new structural information and design experiments based upon it; learn the relative biological importance of the several seemingly redundant adhesion systems; and apply the new insights to the treatment of human diseases. The 1997 Gordon Research Conference on "Fibronectin, Integrins, and Related Macromolecules" will serve as a valuable forum to present and discuss new information, identify problem areas, and plan new approaches.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting of tumor cell DHHC3 to enhance anti-cancer immunity
  • 批准号:
    10116321
  • 项目类别:
  • 资助金额:
    $40.02万
  • 财政年份:
    2020
  • 负责人:
    MARTIN E HEMLER
  • 依托单位:
Targeting of tumor cell DHHC3 to enhance anti-cancer immunity
  • 批准号:
    9884868
  • 项目类别:
  • 资助金额:
    $40.02万
  • 财政年份:
    2020
  • 负责人:
    MARTIN E HEMLER
  • 依托单位:
Targeting of tumor cell DHHC3 to enhance anti-cancer immunity
  • 批准号:
    10357889
  • 项目类别:
  • 资助金额:
    $39.22万
  • 财政年份:
    2020
  • 负责人:
    MARTIN E HEMLER
  • 依托单位:
Targeting of tumor cell DHHC3 to enhance anti-cancer immunity
  • 批准号:
    10578679
  • 项目类别:
  • 资助金额:
    $39.22万
  • 财政年份:
    2020
  • 负责人:
    MARTIN E HEMLER
  • 依托单位:
国内基金
海外基金
益气除痰方促COX-2泛素化修饰调控PEG2/Integrins信号抗肺癌侵袭转移的机制研究
脾虚内环境exosome--integrins通路对肝癌侵袭和转移特性的影响
  • 批准号:
    81873248
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2018
  • 负责人:
    张诗军
  • 依托单位:
IL-32/Integrins/FAK通路在肝纤维化形成中的作用研究
  • 批准号:
    81401306
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2014
  • 负责人:
    潘兴飞
  • 依托单位: